Ontology highlight
ABSTRACT:
PROVIDER: PRJNA932332 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR23362442_1.fastq.gz | Fastqsanger.gz | |||
| SRR23362442_2.fastq.gz | Fastqsanger.gz | |||
| SRR23362443_1.fastq.gz | Fastqsanger.gz | |||
| SRR23362443_2.fastq.gz | Fastqsanger.gz | |||
| SRR23362444_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 6 |
Similar Datasets
Project description:Transcription-Replication Collision Shapes DNA Break Dynamics
| PRJNA1004308 | ENA
Project description:Replication Inhibitors induce DNA DSBs by causing replication-transcription collision.
| PRJNA981191 | ENA
Project description:Replication–transcription conflicts have long been identified as a source of genome instability, leading to DNA double-strand break (DSBs) formation at the site of encounter. These encounter between replication and transcription is significantly increased when cells encounter stress, such as by treatment with agents that alter either of these processes. Alterations in either of these processes increase the probability of their encounter, ultimately inducing DSBs. Previous studies with hydroxyurea (HU)-treated synchronous cell cultures showed that HU-induced DSBs are a result of replication-transcription collisions. Here, we sought to determine whether replication-transcription collision is a general phenomenon used by replication inhibitors to induce DSBs. In our study, we used six different replication inhibitors, HU, methyl methane sulfonate (MMS), camptothecin (CPT), actinomycin D (AD), doxorubicin (DOX), and methotrexate (MTX), each of which acts differently. The replication inhibitor-specific DSBs tend to be enriched at gene exons and are also well correlated with the origins of replication. Gene expression around these DSBs tends to be upregulated, thus increasing the probability of encounter between the two. These results support our hypothesis that DSBs result from replication-transcription conflicts. We also observed enrichment in the transcription-dependent histone mark deposition-H3K4me3 and H3K36me3 at one DSB locus. Taken together, these results suggest that replication inhibitor treatment induces the expression of certain genes, depositing active histone marks, which upon encountering the incoming replication fork result in collision. Overall, our study maps the genome-wide location of DSBs as well as the gene expression profile induced by different replication inhibitors and provides insight into the role of chromatin architecture in regulating genome integrity.
2025-12-31 | GSE297970 | GEO
Project description:TONSOKU prevents the formation of large tandem duplications
| PRJEB106903 | ENA
Project description:Somatic genome rearrangements are thought to play important roles in cancer development. We optimized a long span paired-end-tag (PET) sequencing approach using 10 Kb genomic DNA inserts to study human genome structural variations (SVs). The use of 10 Kb insert size allows the identification of breakpoints within repetitive or homology containing regions of a few Kb in size and results in a higher physical coverage compared to small insert libraries with the same sequencing effort. We have applied this approach to comprehensively characterize the SVs of 15 cancer and 2 non-cancer genomes and used a filtering approach to strongly enrich for somatic SVs in the cancer genomes. Our analyses revealed that most inversions, deletions, and insertions are germline SVs, whereas tandem duplications, unpaired inversions, inter-chromosomal translocations, and complex rearrangements are overrepresented among somatic rearrangements in cancer genomes. We demonstrate that the quantitative and connective nature of DNA-PET data is precise in delineating the genealogy of complex rearrangement events, we observe signatures which are compatible with breakage-fusion-bridge cycles, and discover that large duplications are among the initial rearrangements that trigger genome instability for extensive amplification in epithelial cancers. Structural variations of 15 human cancer samples and 2 human normal samples were identified by long span paired-end sequencing
2011-04-06 | E-GEOD-26954 | biostudies-arrayexpress
Project description:Replication–transcription conflicts have long been identified as a source of genome instability, leading to DNA double-strand break (DSBs) formation at the site of encounter. The encounter between replication and transcription is significantly increased when cells encounter stress, such as by treatment with agents that alter either of these processes. Alterations in either of these processes increase the probability of their encounter, ultimately inducing DSBs. Previous studies with hydroxyurea (HU)-treated synchronous cell cultures showed that HU-induced DSBs are a result of replication-transcription collisions. Here, we sought to determine whether replication-transcription collision is a general phenomenon used by replication inhibitors to induce DSBs. In our study, we used six different replication inhibitors, HU, methyl methane sulfonate (MMS), camptothecin (CPT), actinomycin D (AD), doxorubicin (DOX), and methotrexate (MTX), each of which acts differently. The replication inhibitor-specific DSBs tend to be enriched at gene exons and are also well correlated with the origins of replication. Gene expression around these DSBs tends to be upregulated, thus increasing the probability of encounter between the two. These results support our hypothesis that DSBs result from replication-transcription conflicts. We also observed enrichment in the transcription-dependent histone mark deposition-H3K4me3 and H3K36me3 at one DSB locus. Taken together, these results suggest that replication inhibitor treatment induces the expression of certain genes, depositing active histone marks, which upon encountering the incoming replication fork result in collision. Overall, our study maps the genome-wide location of DSBs as well as the gene expression profile induced by different replication inhibitors and provides insight into the role of chromatin architecture in regulating genome integrity.
2025-12-31 | GSE234409 | GEO
Project description:Replication–transcription conflicts have long been identified as a source of genome instability, leading to DNA double-strand break (DSBs) formation at the site of encounter. The encounter between replication and transcription is significantly increased when cells encounter stress, such as by treatment with agents that alter either of these processes. Alterations in either of these processes increase the probability of their encounter, ultimately inducing DSBs. Previous studies with hydroxyurea (HU)-treated synchronous cell cultures showed that HU-induced DSBs are a result of replication-transcription collisions. Here, we sought to determine whether replication-transcription collision is a general phenomenon used by replication inhibitors to induce DSBs. In our study, we used six different replication inhibitors, HU, methyl methane sulfonate (MMS), camptothecin (CPT), actinomycin D (AD), doxorubicin (DOX), and methotrexate (MTX), each of which acts differently. The replication inhibitor-specific DSBs tend to be enriched at gene exons and are also well correlated with the origins of replication. Gene expression around these DSBs tends to be upregulated, thus increasing the probability of encounter between the two. These results support our hypothesis that DSBs result from replication-transcription conflicts. We also observed enrichment in the transcription-dependent histone mark deposition-H3K4me3 and H3K36me3 at one DSB locus. Taken together, these results suggest that replication inhibitor treatment induces the expression of certain genes, depositing active histone marks, which upon encountering the incoming replication fork result in collision. Overall, our study maps the genome-wide location of DSBs as well as the gene expression profile induced by different replication inhibitors and provides insight into the role of chromatin architecture in regulating genome integrity.
2025-12-31 | GSE234408 | GEO
Project description:Replication–transcription conflicts have long been identified as a source of genome instability, leading to DNA double-strand break (DSBs) formation at the site of encounter. The encounter between replication and transcription is significantly increased when cells encounter stress, such as by treatment with agents that alter either of these processes. Alterations in either of these processes increase the probability of their encounter, ultimately inducing DSBs. Previous studies with hydroxyurea (HU)-treated synchronous cell cultures showed that HU-induced DSBs are a result of replication-transcription collisions. Here, we sought to determine whether replication-transcription collision is a general phenomenon used by replication inhibitors to induce DSBs. In our study, we used six different replication inhibitors, HU, methyl methane sulfonate (MMS), camptothecin (CPT), actinomycin D (AD), doxorubicin (DOX), and methotrexate (MTX), each of which acts differently. The replication inhibitor-specific DSBs tend to be enriched at gene exons and are also well correlated with the origins of replication. Gene expression around these DSBs tends to be upregulated, thus increasing the probability of encounter between the two. These results support our hypothesis that DSBs result from replication-transcription conflicts. We also observed enrichment in the transcription-dependent histone mark deposition-H3K4me3 and H3K36me3 at one DSB locus. Taken together, these results suggest that replication inhibitor treatment induces the expression of certain genes, depositing active histone marks, which upon encountering the incoming replication fork result in collision. Overall, our study maps the genome-wide location of DSBs as well as the gene expression profile induced by different replication inhibitors and provides insight into the role of chromatin architecture in regulating genome integrity.
2025-12-31 | GSE297969 | GEO
Project description:Replication–transcription conflicts have long been identified as a source of genome instability, leading to DNA double-strand break (DSBs) formation at the site of encounter. The encounter between replication and transcription is significantly increased when cells encounter stress, such as by treatment with agents that alter either of these processes. Alterations in either of these processes increase the probability of their encounter, ultimately inducing DSBs. Previous studies with hydroxyurea (HU)-treated synchronous cell cultures showed that HU-induced DSBs are a result of replication-transcription collisions. Here, we sought to determine whether replication-transcription collision is a general phenomenon used by replication inhibitors to induce DSBs. In our study, we used six different replication inhibitors, HU, methyl methane sulfonate (MMS), camptothecin (CPT), actinomycin D (AD), doxorubicin (DOX), and methotrexate (MTX), each of which acts differently. The replication inhibitor-specific DSBs tend to be enriched at gene exons and are also well correlated with the origins of replication. Gene expression around these DSBs tends to be upregulated, thus increasing the probability of encounter between the two. These results support our hypothesis that DSBs result from replication-transcription conflicts. We also observed enrichment in the transcription-dependent histone mark deposition-H3K4me3 and H3K36me3 at one DSB locus. Taken together, these results suggest that replication inhibitor treatment induces the expression of certain genes, depositing active histone marks, which upon encountering the incoming replication fork result in collision. Overall, our study maps the genome-wide location of DSBs as well as the gene expression profile induced by different replication inhibitors and provides insight into the role of chromatin architecture in regulating genome integrity.
2025-12-31 | GSE234410 | GEO